Skip to content

Sabra Healthcare SBRA Payments To Acquire Real Estate

Payments To Acquire Real Estate at other companies

American Healthcare REIT logo
American Healthcare REITAHR
$165.94M+909%
Healthcare Realty Trust logo
Healthcare Realty TrustHR
$2.12M
Equity Residential logo
Equity ResidentialEQR
$23.66M-91.4%

Other financials

Income statement

See full
Revenue$221.8M+20.8%
Net income$40.9M+1.4%
EPS (diluted)$0.16-5.9%

Balance sheet

See full
Cash & equivalents$116.5M+414%
Total debt$7.3M-9.6%
Total equity$2.8B+3.1%
Total assets$5.6B+6.8%

Cash flow

See full
Operating cash flow$98.4M+22.5%

Valuation

See full
Market cap$4.57B+16.7%

Profitability

See full
Net margin19.2%-0.3pp

Returns & leverage

See full
Return on equity5.7%+0.5pp
Debt / equity0.0×

Where this comes from

Reported directly by Sabra Healthcare in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireRealEstate.

The official record: Sabra Healthcare’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sabra Healthcare's payments to acquire real estate.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sabra Healthcare's payments to acquire real estate?
Sabra Healthcare (SBRA) reported payments to acquire real estate of $96.1M in Q1 2026.
How has Sabra Healthcare's payments to acquire real estate changed year-over-year?
Sabra Healthcare's payments to acquire real estate increased by 1123.6% year-over-year, from $7.85M to $96.1M.
What is the long-term trend for Sabra Healthcare's payments to acquire real estate?
Over 3 years (2021 to 2025), Sabra Healthcare's payments to acquire real estate has grown at a 65.8% compound annual growth rate (CAGR), from $99.45M to $452.93M.
What does payments to acquire real estate mean?
Captures the total cash outflow for the purchase of new healthcare properties or land. This metric is a primary indicator of the company's external growth strategy and capital deployment pace.